CNS Pharmaceuticals (CNSP) Institutional Ownership $3.29 -0.46 (-12.27%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$3.16 -0.13 (-3.95%) As of 02/21/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for CNS Pharmaceuticals (NASDAQ:CNSP)CurrentInstitutional OwnershipPercentage14.02%Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$85.09MNumber ofInstitutional Sellers(last 12 months)0 Get CNSP Insider Trade Alerts Want to know when executives and insiders are buying or selling CNS Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CNSP Institutional Buying and Selling by Quarter CNS Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/18/2025 Connective Capital Management LLC280,055$34K0.0%N/A0.487% 2/17/2025 Citadel Advisors LLC321,874$39K0.0%N/A0.560% 2/14/2025 Jane Street Group LLC419,737$51K0.0%+1,712.3%0.730% 2/14/2025 Integrated Wealth Concepts LLC250,000$30K0.0%N/A0.435% 2/13/2025 XTX Topco Ltd294,919$36K0.0%N/A0.513% 2/12/2025 Geode Capital Management LLC387,064$47K0.0%+90.5%0.673% 2/7/2025 Wealthfront Advisers LLC216,046$26K0.0%N/A0.376% 5/20/2024 Virtu Financial LLC94,246$34K0.0%+616.6%0.795% 2/13/2024 Armistice Capital LLC122,000$155K0.0%N/A1.965% 1/17/2024 Smith Anglin Financial LLC50,000$64K0.0%N/A0.952% Get the Latest News and Ratings for CNSP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CNS Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/7/2023 Acadian Asset Management LLC22,292$49K0.0%N/A1.000% 7/12/2023 FSM Wealth Advisors LLC16,334$38K0.0%N/A0.732% 9/17/2021 Virtu Financial LLC20,745$41K0.0%-49.8%0.076% 8/13/2021 Renaissance Technologies LLC432,109$847K0.0%-40.2%1.704% 8/13/2021 Geode Capital Management LLC100,196$196K0.0%+64.8%0.395% 8/13/2021 Vanguard Group Inc.599,309$1.18M0.0%+326.6%2.363% 8/11/2021 Commonwealth Equity Services LLC20,000$39K0.0%N/A0.079% 5/19/2021 Virtu Financial LLC41,310$99K0.0%N/A0.163% 5/18/2021 Citadel Advisors LLC92,404$221K0.0%N/A0.364% 5/18/2021 Jane Street Group LLC13,747$33K0.0%N/A0.054% 5/17/2021 Goldman Sachs Group Inc.11,566$28K0.0%N/A0.046% 5/13/2021 Renaissance Technologies LLC722,760$1.73M0.0%N/A2.850% 5/13/2021 Bank of New York Mellon Corp43,659$104K0.0%N/A0.172% 5/12/2021 Northern Trust Corp32,094$77K0.0%N/A0.127% 5/12/2021 Geode Capital Management LLC60,784$145K0.0%N/A0.240% 2/16/2021 Warberg Asset Management LLC14,000$25K0.0%N/A0.059% (Data available from 1/1/2016 forward) CNSP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CNSP shares? During the previous two years, 12 institutional investors and hedge funds held shares of CNS Pharmaceuticals. The most heavily invested institutionals were Armistice Capital LLC ($155K), Smith Anglin Financial LLC ($64K), Jane Street Group LLC ($51K), Acadian Asset Management LLC ($49K), Geode Capital Management LLC ($47K), Citadel Advisors LLC ($39K), and FSM Wealth Advisors LLC ($38K).Learn more on CNSP's institutional investors. What percentage of CNS Pharmaceuticals stock is owned by institutional investors? 14.02% of CNS Pharmaceuticals stock is owned by institutional investors. Learn more on CNSP's institutional investor holdings. Which institutional investors have been buying CNS Pharmaceuticals stock? Of the 12 institutional investors that purchased CNS Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Jane Street Group LLC ($396.58K), Citadel Advisors LLC ($321.87K), XTX Topco Ltd ($294.92K), Connective Capital Management LLC ($280.06K), Integrated Wealth Concepts LLC ($250K), Wealthfront Advisers LLC ($216.05K), and Geode Capital Management LLC ($183.88K). How much institutional buying is happening at CNS Pharmaceuticals? Institutional investors have bought a total of 2,235,075 shares in the last 24 months. This purchase volume represents approximately $846.53M in transactions. Related Companies ENLV Institutional Ownership DRRX Institutional Ownership CTXR Institutional Ownership CARA Institutional Ownership TNXP Institutional Ownership SXTP Institutional Ownership CDIO Institutional Ownership LSB Institutional Ownership LGVN Institutional Ownership LSTA Institutional Ownership This page (NASDAQ:CNSP) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | Sponsored$5,000 DOGE check?Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a porti...Altimetry | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored2025 AI Blueprint features Nvidia’s march to $5 trillionNvidia is now one of the most valuable companies in the world. It currently ranks second, just behind Apple...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CNS Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CNS Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
